پمفیگوس ولگاریس لثه ای در بیماران جوان:گزارش موارد

Authors

  • شیوا, آتنا استادیار، گروه آسیب شناسیدهان و فک و صورت ، دانشکده دندانپزشکی، دانشگاه علوم پزشکی مازندران، ساری، ایران
  • معبودی, آویده استادیار، گروه پریودنتیکس، دانشکده دندانپزشکی، دانشگاه علوم پزشکی مازندران، ساری، ایران
Abstract:

Pemphigus vulgaris is an autoimmune and rare mucocutaneous disease with outbreak of 1 to 5 patients per 1 million people. The average age at onset of disease is usually 50 years. In this study four young females (mean age: 27.75 years) with pemphigus vulgaris are presented. The first patient was a 28-year-old female complaining from various oral sores. She was diagnosed with pemphigus vulgaris based on biopsy. After treatment for 12 months, no sores were seen in other parts of her body. The second case was a 23-year-old woman with facial desquamation of upper and lower jaws. In pathology of oral lesions the diagnosis of pemphigus vulgaris was made and within 11 months follow-up after treatment, only the oral sores improved. The next patient was 30 years of age who had desquamated gingivitis and exclusive oral sores. She was also diagnosed with the same disease. After 12 months follow-up, oral lesions were controlled and no sores were seen in other parts of the body. The last case was a 36-year-old female with severe sores in the mouth associated with pemphigus vulgaris. But within 11 months of follow-up, despite treatments, the disease developed and large sores and blisters were seen throughout her body. Pemphigus vulgaris is a serious disease that can lead to death if left untreated. The oral lesions are the first symptoms of this disease, but the clinical appearance of these lesions are not sores, therefore, biopsy and early diagnoses are required to prevent further complications.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

سطح سرمی آنتی‌اکسیدان‌ها در بیماران مبتلا به پمفیگوس ولگاریس

   Background & Aims: Pemphigus comprises a group of autoimmune life threading diseases characterized by cutaneous and mucosal blistering. Pemphigus vulgaris (PV) is the most common and important variant. Recent reports have revealed the relatively high incidence of PV in Iran. The onset or aggravation of many human diseases is attributed to oxidative stress and it has been suggested as one of ...

full text

اثربخشی مایکوفنولات موفتیل در درمان بیماران مبتلا به پمفیگوس ولگاریس مقاوم به درمان

Background and Aim: Pemphigus is one of the most common types of autoimmune blistering disease that requires systemic immunosuppressive therapy. Immunosuppressive therapy has improved the disease outcome in recent decades, but long-term use of them has side effects. Recently, it has been tried to evaluate immunosuppressive drugs with less side effects. One of them is mycophenolate mofetil. The ...

full text

تأثیر اجرای الگوی توانمندسازی خانواده محور بر کیفیت زندگی عمومی بیماران زن مبتلا به پمفیگوس ولگاریس

مقدمه: پمفیگوس ولگاریس یک بیماری مزمن پوستی درگیر کننده پوست و ضمائم آن است و کیفیت زندگی بیمار و خانواده را تحت تأثیر قرار می‌دهد. هدف مطالعه حاضر تعیین تأثیر اجرای الگوی توانمندسازی خانواده محور بر کیفیت زندگی بیماران مبتلا به پمفیگوس ولگاریس است. روش کار: این مطالعه کارآزمایی بالینی شاهددار همسان شده با انتخاب 72 بیمار زن مبتلا به پمفیگوس ولگاریس از طریق نمونه گیری مبتنی بر هدف و تخصیص تصاد...

full text

رابطه گروه خون وRH با بروز بیماری پمفیگوس ولگاریس

One hundred patients were studied and 93 of them suffered from Pemphigus Vulgaris and 7 of them were suffered from Pemphigus Foliaceus. The results were compared with control group. Results : There is not relationship between blood group and Pemphigus, but incidence of Pemphigus in Rh+ patients is more than Rh- patients.

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 26  issue 142

pages  270- 276

publication date 2016-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023